tetano
Editor, Senior Moderator
Cytokine. 2019 May 2;120:115-124. doi: 10.1016/j.cyto.2019.04.019. [Epub ahead of print]
[h=1]Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1β mediated neutrophil recruitment.[/h] Niu J[SUP]1[/SUP], Wu S[SUP]2[/SUP], Chen M[SUP]2[/SUP], Xu K[SUP]2[/SUP], Guo Q[SUP]2[/SUP], Lu A[SUP]2[/SUP], Zhao L[SUP]3[/SUP], Sun B[SUP]2[/SUP], Meng G[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Host innate immune system is critical for combating invading microbes including Influenza A virus (IAV). As an important arm of the innate immunity, the NLRP3 inflammasome has been found essential for protecting host against IAV challenge, while the mechanism remained elusive. Here we found that mice carrying a gain-of-function mutation in the Nlrp3 gene (Nlrp3[SUP]R258W[/SUP]) are strongly resistant to IAV infection. Upon H1N1 IAV infection, the Nlrp3[SUP]R258W[/SUP] mice exhibited decreased weight loss, increased survival rate and attenuated lung damage compared with WT littermate controls. Mechanistically, the resistance of Nlrp3[SUP]R258W[/SUP] mice to IAV infection was dependent on IL-1β-mediated neutrophil recruitment. Upon IAV infection, mice carrying the Nlrp3[SUP]R258W[/SUP] mutation produced more IL-1β than WT mice in the lung, which enhanced neutrophil recruitment locally. The recruited neutrophils facilitated IAV clearance, so that the viral load in Nlrp3[SUP]R258W[/SUP] mice was lower than that in control mice. Conversely, neutrophil depletion in Nlrp3[SUP]R258W[/SUP] mice compromised IAV clearance. Taken together, our results demonstrate a previously undescribed mechanism by which hyperactivation of the NLRP3 Inflammasome protects mice from IAV infection through IL-1β mediated neutrophil recruitment, thus suggest that positively fine tuning the physiological function of NLRP3 inflammasome can be beneficial for a mammalian host against IAV challenge.
Copyright ? 2019 Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] Influenza; NLRP3 inflammasome; Neutrophil
PMID: 31055218 DOI: 10.1016/j.cyto.2019.04.019
[h=1]Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1β mediated neutrophil recruitment.[/h] Niu J[SUP]1[/SUP], Wu S[SUP]2[/SUP], Chen M[SUP]2[/SUP], Xu K[SUP]2[/SUP], Guo Q[SUP]2[/SUP], Lu A[SUP]2[/SUP], Zhao L[SUP]3[/SUP], Sun B[SUP]2[/SUP], Meng G[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Host innate immune system is critical for combating invading microbes including Influenza A virus (IAV). As an important arm of the innate immunity, the NLRP3 inflammasome has been found essential for protecting host against IAV challenge, while the mechanism remained elusive. Here we found that mice carrying a gain-of-function mutation in the Nlrp3 gene (Nlrp3[SUP]R258W[/SUP]) are strongly resistant to IAV infection. Upon H1N1 IAV infection, the Nlrp3[SUP]R258W[/SUP] mice exhibited decreased weight loss, increased survival rate and attenuated lung damage compared with WT littermate controls. Mechanistically, the resistance of Nlrp3[SUP]R258W[/SUP] mice to IAV infection was dependent on IL-1β-mediated neutrophil recruitment. Upon IAV infection, mice carrying the Nlrp3[SUP]R258W[/SUP] mutation produced more IL-1β than WT mice in the lung, which enhanced neutrophil recruitment locally. The recruited neutrophils facilitated IAV clearance, so that the viral load in Nlrp3[SUP]R258W[/SUP] mice was lower than that in control mice. Conversely, neutrophil depletion in Nlrp3[SUP]R258W[/SUP] mice compromised IAV clearance. Taken together, our results demonstrate a previously undescribed mechanism by which hyperactivation of the NLRP3 Inflammasome protects mice from IAV infection through IL-1β mediated neutrophil recruitment, thus suggest that positively fine tuning the physiological function of NLRP3 inflammasome can be beneficial for a mammalian host against IAV challenge.
Copyright ? 2019 Elsevier Ltd. All rights reserved.
[h=4]KEYWORDS:[/h] Influenza; NLRP3 inflammasome; Neutrophil
PMID: 31055218 DOI: 10.1016/j.cyto.2019.04.019